The pharmaceutical industry argues that because new drugs will not be developed unless heavy development costs can be recouped in later sales, the current 20 years of protection provided by patents should be extended in the case of newly developed drugs. However, in other industries new-product development continues despite high development costs, a fact that indicates that the extension is unnecessary.
Which of the following, if true, most strongly supports the pharmaceutical industry's argument against the challenge made above?
113 The pharmaceutical industry argues that because new drugs will not be developed unless heavy development costs can be recouped in later sales, the current 20 years of protection provided by patents should be extended in the case of newly developed drugs. However, in other industries new-product development continues despite high development costs, a fact that indicates that the extension is unnecessary. Which of the following, if true, most strongly supports the pharmaceutical industry’s argument against the challenge made above?
(A) No industries other than the pharmaceutical industry have asked for an extension of the 20-year limit on patent protection. (B) Clinical trials of new drugs, which occur after the patent is granted and before the new drug can be marketed, often now take as long as 10 years to complete. (C) There are several industries in which the ratio of research and development costs to revenues is higher than it is in the pharmaceutical industry. (D) An existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market alternative drugs, provided they are sufficiently dissimilar to the patented drug. (E) Much recent industrial innovation has occurred in products—for example, in the computer and electronics industries—for which patent protection is often very ineffective.
113 The pharmaceutical industry argues that because new drugs will not be developed unless heavy development costs can be recouped in later sales, the current 20 years of protection provided by patents should be extended in the case of newly developed drugs. However, in other industries new-product development continues despite high development costs, a fact that indicates that the extension is unnecessary. Which of the following, if true, most strongly supports the pharmaceutical industry’s argument against the challenge made above?
原文说要有专利需要EX-大概需要20年,而其他行业不需要,问支持。
(A) No industries other than the pharmaceutical industry have asked for an extension of the 20-year limit on patent protection.
other than the pharmaceutical-范围不对,杀
(B) Clinical trials of new drugs, which occur after the patent is granted and before the new drug can be marketed, often now take as long as 10 years to complete.
临床试验需要时间什么的,沾,先放着
(C) There are several industries in which the ratio of research and development costs to revenues is higher than it is in the pharmaceutical industry.
ratio不可得知,杀
(D) An existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market alternative drugs, provided they are sufficiently dissimilar to the patented drug.
does not legally prevent 驳斥原文,杀
(E) Much recent industrial innovation has occurred in products—for example, in the computer and electronics industries—for which patent protection is often very ineffective.
(A) No industries other than the pharmaceutical industry have asked for an extension of the 20-year limit on patent protection.(无关选项/或方向相反。其他工厂的情况可能跟制药厂不同。即使这句话成立,也是weaken了制药厂的argument)
(B) Clinical trials of new drugs, which occur after the patent is granted and before the new drug can be marketed, often now take as long as 10 years to complete.(新信息。新药品的临床试验就花了10年,原来专利年限是20年,这样也就是浪费了10年的专利,这10年是没有回报的,所以可能需要延长专利来收回成本)
(C) There are several industries in which the ratio of research and development costs to revenues is higher than it is in the pharmaceutical industry.(跟专利扯不上关系呀!!即使有关,说成本利润比值高,只能说明成本高,然后呢。。然后呢。。然后就没有然后了。。。所以不能选呀!!)
(D) An existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market alternative drugs, provided they are sufficiently dissimilar to the patented drug.(方向相反。既然既有的专利都不能保护了,延长年限也保护不了呀!所以不需要延长年限,所以支持了第二个观点,但题干要我们选支持第一个观点的)
(E) Much recent industrial innovation has occurred in products—for example, in the computer and electronics industries—for which patent protection is often very ineffective.(无关/方向相反。不同工厂能比吗?即使能比,都说专题保护无效了,延长了也无效,所以不需要。同D)
01. 首先要读懂题目问的是什么!!!题目的意思是问哪个选项支持制药厂的观点,而不是削弱呀!!!
supports the pharmaceutical industry’s argument才是重点呀!!!against the challenge 是修饰argument的!!!这里的challenge是第二个观点,也就是说不需要延长专利年限的那个观点。第二个观点是第一个观点的challenge, 第一个观点与第二个观点对立,所以是against the challenge ,反对第二个观点!!!
02. 所以这道题所要支持的是pharmaceutical industry’s argument,第一句话的观点!!也就是支持需要延长制药厂新药品的专利年限。03.渣渣的我发现搞清方向特别重要